← Back to all trials
Not Yet Recruiting
NCT05667935
Cognitive Impairment Cohort Study of the Elderly Population in SheMountain
Conditions: Alzheimer Disease, Dementia, Neurodegenerative Diseases, Cognitive Impairment, Mild Cognitive Impairment
Sex: All
Ages: 60 Years – N/A
Healthy volunteers: 1
Enrollment: 2000
Sponsor: Ruijin Hospital
Location: China
Summary
This study is a prospective observational study, which involves a cohort of 2000 all-sex and all-ethnic people aged 60 years and above with permanent residence in Tianma area, SheMountain Town, Songjiang District (suburban area), Shanghai.
Demographic information, neuropsychiatric scale, peripheral blood, APOE genotype, brain MRI, speech information, AV45-PET, FDG-PET, Tau-PET, GLP-1R PET, and cholinergic receptor probe (ASEM) PET were collected and analyzed.
Follow-up visits were performed twice a year for 4 visits, and neuropsychiatric scales and biological samples were collected at each follow-up visit to construct a diagnostic model for patients with mild cognitive impairment, or Alzheimer's disease, as well as a predictive model for the progression of cognitive impairment.
Eligibility Criteria
Inclusion Criteria:All genders and all ethnic groups aged 60 and above with permanent residence in Tianma area, SheMountain Town, Songjiang District (suburbs), Shanghai.Agree to collect neuropsychiatric scales, biological samples, imaging and other examination information.Agree to participate in this study and sign the informed consent form.
And promise to abide by the research procedures, and cooperate with the implementation of the whole process of researchExclusion Criteria:Suffering from severe mental illness, tumor cachexia, severe liver and kidney dysfunction and other serious physical diseases and unable to cooperateUncorrectable visual or auditory impairment that hampers the completion of related examination.
Source: ClinicalTrials.gov (NCT05667935). StuddyBuddy aggregates publicly available trial information.